Naobios provides bioprocess development and contract manufacturing services for viral vaccines and viral vectors. The company was acquired by Clean Biologics on March 1st, 2019 and now supports clients for process development and the manufacture of preclinical and clinical batches.

Naobios

#RECRUTEMENT - Nouvelle opportunité chez Naobios
🔎 Ingénieur Qualification (H/F), en CDI
➡️ Pour candidater, c'est ici: https://lnkd.in/enJ6NsAu 

#RECRUTEMENT - Nouvelle opportunité chez Naobios !
🔎 Business Developer, Permanent Position
➡️ Pour candidater, c'est ici : https://lnkd.in/eWgR3Qbn

Need support for GMP manufacturing of your vaccines, oncolytic viruses or challenge agents? 
With over 15 years' experience in process development and GMP manufacturing for clinical development, Naobios is your partner of choice for your virus-derived products !🔬🦠

◾ USP & DSP development capacities
◾ BSL2 & BSL3 GMP manufacturing
◾ Analytical development & validation
◾ GMP storage

You need more informations ? Contact us ! ➡️ https://lnkd.in/enFcEWQ4

#CDMO #vaccines #oncolyticviruses #challengeagents #manufacturing

Aujourd'hui Clean Cells et Naobios étaient présentes au forum des Métiers ouvert à l'ensemble des étudiants d'Oniris Nantes.

Les étudiants ont pu se projeter sur les métiers du domaine de la Biotechnologie, notamment grâce au partage d'expérience de Juliette Ambrosini et Céleste Ory, anciennes élèves d'Oniris désormais salariées du groupe CLEAN BIOLOGICS.

Merci à Oniris pour votre accueil, et merci aux étudiants qui sont venus à notre rencontre ! Au plaisir de futures collaborations !

#ForumdesMétiers #etudiants #talents #recrutement #RH Hélène Mercier

Extracellular vesicles (EVs) play an important role in the intercellular communication and are involved in physiological and pathological functions. They are attracting significant clinical interest for drug delivery, disease diagnosis and therapeutic intervention. EVs properties make their use promising for applications such as tissue regeneration and nano carriers able to cross biological barriers. To position EVs as new biotherapeutics, some of the current challenges are increasing production yields and improving quantification and characterization.

Thanks to its recognized experience in cell culture based process development, Naobios has the capabilities to implement bioreactors based platforms (stirred tank and fixed-bed) as well as EVs purification steps through filtration and chromatographic techniques.

Naobios is the right partner to make your EVs manufacturing processes compatible with industrial scale-up and GMP requirements.

#EVs #exosomes #purification #filtration #chromato #manufacturing #GMP 

| 📢 #BIOEurope2023 |

Last day to meet Luís Raiado from Naobios & François Pedelaborde from Clean Cells at the Bio-Europe Congress in Munich.

If you don't have the opportunity to meet them before tonight, please don't hesitate to contact us on our website. We'll be pleased to discuss about your upcoming projects ➡️ https://lnkd.in/enFcEWQ4

#congress #CRO #CDMO #bioprocessdevelopment #manufacturing CLEAN BIOLOGICS

VentureRadar provides innovation and growth scores, company information, and location for similar companies and competitors in the biotechnology industry.

VentureRadar

Biocompare shares updated information on viral vector production platforms, including transient transfection, and features leading companies in the gene therapy industry.

Biocompare

Clean Biologics has developed bioprocesses and manufactured BSL2/BSL3 viral vectors for clinical use in modalities such as viral vaccines, aligning with Naobios' expertise in viral vector-based products.

Clean Biologics

GlobalData uncovers leading innovators in gene therapy viral vectors for the pharmaceutical industry, providing valuable insights into companies driving advancements in viral vector-based products.

GlobalData

Naobios is a biotechnology company that specializes in the development and manufacturing of viral vector-based products for gene therapy and vaccination. The company offers a range of services including process development, GMP manufacturing, quality control, and regulatory support to advance therapies from early-stage research to clinical trials.

industry trends dossier	dataroom
company dossier	dataroom
network	dataroom
network mapping	dataroom
transactions dossier	dataroom
network onboarding	dataroom
news impact assignment basic	general
public peers	general	May 12, 2024 3:58 PM	e7b1d843
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	May 12, 2024 9:44 PM	9cece234
company summary	general
signals	general
news advanced	general
news impact assignment advanced	general
news processing advanced	general
peers	general
news basic	general	May 12, 2024 3:58 PM	b1204645
events	markdown
bundesanzeiger	filings
financial statements	filings
regulatory analysis	company_analysis
industry analysis	company_analysis
swot analysis	company_analysis
competition analysis	company_analysis
financial legal advisories	company_analysis
merger acquisitions	company_analysis
customer profile	customers

COM:NAOBIOS

Naobios